1. Scrip
  3. >>Alimentary/Metabolic

US Capitol Capsule: Obama superbug attack plan hinges on funding, cooperation

 
• By Donna Young

President Barack Obama on 27 March unveiled an aggressive five-year plan to combat the growing scourge of superbugs, which infect about 2 million Americans each year, killing 23,000.

President Barack Obama on 27 March unveiled an aggressive five-year plan to combat the growing scourge of superbugs, which infect about 2 million Americans each year, killing 23,000.

The plan was developed in response to an 18 September 2014 executive order issued by Mr Obama and outlines the steps for implementing his multi-pronged strategy for attacking antimicrobial resistance (AMR) and addressing the policy recommendations from the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Alimentary/Metabolic

Novo Nordisk’s CEO Forced Out After Falling Behind In GLP-1 Battle

 
• By Andrew McConaghie

Company surprises investors with Jørgensen's exit but insists its strategy will not change.

Multiple Launches Help Lilly’s Japan Growth

 
• By Ian Haydock

Lilly saw solid growth for its business in Japan last year on the back of several new launches and is building its obesity and Alzheimer's portfolios in the country.

Novo Nordisk Looks To Septerna For Oral Obesity Options

 
• By Mary Jo Laffler

Deal Snapshot: The Danish drugmaker is partnering with GPCR drug discovery expert Septerna to develop multiple small molecules for cardiometabolic targets.

GSK Pays $1.2bn For Phase III-Ready MASH Contender

 
• By Andrew McConaghie

The acquisition of Boston Pharma’s once-a-month FGF21 analog adds to GSK’s liver disease portfolio.

More from Therapy Areas